Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The G antigen pseudogene (ENSG00000250393) is annotated as a human pseudogene[1][3]. Pseudogenes are genomic sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements[2]. ENSG00000250393 is expressed in testis and various other tissues, but there is no evidence that it encodes a protein or has a clinical or therapeutic role[3]. The related “G antigen” in transfusion medicine refers to an Rh antigen implicated in hemolytic disease and transfusion reactions, but this is a protein epitope, not a gene target, and does not describe the pseudogene ENSG00000250393[4]. The "G antigen pseudogene" is not an actionable drug target, receptor, enzyme, transporter, or therapeutic biomolecule. It is a pseudogene (part of the non-coding RNA family) and does not have known canonical protein expression or therapeutic functions[1][2][3]. Its designation as a target is likely based on confusion with the functional G antigen protein epitope found on red blood cells[4], but this functional protein is not encoded by ENSG00000250393. There is no evidence for interacting small molecules, drugs, or biomarker status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G antigen pseudogene.